Guidelines for Neuroleptic Relapse Prevention in Schizophrenia: Proceedings of a Consensus Conference held April 19–20, 1989, in Bruges, Belgium
How neuroleptics are used in relapse prevention is a very controversial topic. Fifty percent of all schizo- phrenic patients do not receive sufficient prophylactic treatment and suffer from frequent relapses. To help correct this situation, leading international experts in the field of neuroleptic r...
Gespeichert in:
| Weitere beteiligte Personen: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | Englisch |
| Veröffentlicht: |
Berlin, Heidelberg
Springer Berlin Heidelberg
1991
|
| Schlagwörter: | |
| Links: | https://doi.org/10.1007/978-3-642-86922-8 https://doi.org/10.1007/978-3-642-86922-8 |
| Zusammenfassung: | How neuroleptics are used in relapse prevention is a very controversial topic. Fifty percent of all schizo- phrenic patients do not receive sufficient prophylactic treatment and suffer from frequent relapses. To help correct this situation, leading international experts in the field of neuroleptic relapse prevention (n.r.p.) agreed upon guidelines after intensive discussions at a consensus workshop in Bruges in April 1989. Precise guidelines to the most important questions on n.r.p. are formu- lated, especially concerning indications, treatment duration and dosage. The current state of the literature on these questions is presented in comprehensive reviews. For the practicing psychiatrist or general practitioner, exact guidelines for prophylactic treatment are presented; for patients and their families eager to obtain more information, the scientific basis of the treatment is explained |
| Umfang: | 1 Online-Ressource (X, 166 p) |
| ISBN: | 9783642869228 |
| DOI: | 10.1007/978-3-642-86922-8 |
Internformat
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV046147006 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190905s1991 xx o|||| 00||| eng d | ||
| 020 | |a 9783642869228 |9 978-3-642-86922-8 | ||
| 024 | 7 | |a 10.1007/978-3-642-86922-8 |2 doi | |
| 035 | |a (ZDB-2-SME)978-3-642-86922-8 | ||
| 035 | |a (OCoLC)1119131599 | ||
| 035 | |a (DE-599)BVBBV046147006 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 616.89 |2 23 | |
| 084 | |a YH 6105 |0 (DE-625)153561:12911 |2 rvk | ||
| 245 | 1 | 0 | |a Guidelines for Neuroleptic Relapse Prevention in Schizophrenia |b Proceedings of a Consensus Conference held April 19–20, 1989, in Bruges, Belgium |c edited by Werner Kissling |
| 264 | 1 | |a Berlin, Heidelberg |b Springer Berlin Heidelberg |c 1991 | |
| 300 | |a 1 Online-Ressource (X, 166 p) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 520 | |a How neuroleptics are used in relapse prevention is a very controversial topic. Fifty percent of all schizo- phrenic patients do not receive sufficient prophylactic treatment and suffer from frequent relapses. To help correct this situation, leading international experts in the field of neuroleptic relapse prevention (n.r.p.) agreed upon guidelines after intensive discussions at a consensus workshop in Bruges in April 1989. Precise guidelines to the most important questions on n.r.p. are formu- lated, especially concerning indications, treatment duration and dosage. The current state of the literature on these questions is presented in comprehensive reviews. For the practicing psychiatrist or general practitioner, exact guidelines for prophylactic treatment are presented; for patients and their families eager to obtain more information, the scientific basis of the treatment is explained | ||
| 650 | 4 | |a Psychiatry | |
| 650 | 4 | |a Psychiatry | |
| 650 | 0 | 7 | |a Neuroleptikum |0 (DE-588)4041885-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Internationaler Vergleich |0 (DE-588)4120509-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Rezidivprophylaxe |0 (DE-588)4177967-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Schizophrenie |0 (DE-588)4052527-2 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1989 |z Brügge |2 gnd-content | |
| 689 | 0 | 0 | |a Schizophrenie |0 (DE-588)4052527-2 |D s |
| 689 | 0 | 1 | |a Neuroleptikum |0 (DE-588)4041885-6 |D s |
| 689 | 0 | 2 | |a Rezidivprophylaxe |0 (DE-588)4177967-8 |D s |
| 689 | 0 | 3 | |a Internationaler Vergleich |0 (DE-588)4120509-1 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Kissling, Werner |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783540539858 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783642869235 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-642-86922-8 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SME | ||
| 940 | 1 | |q ZDB-2-SME_1990/2004 | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-031527191 | |
| 966 | e | |u https://doi.org/10.1007/978-3-642-86922-8 |l DE-355 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1818986033765679104 |
|---|---|
| any_adam_object | |
| author2 | Kissling, Werner |
| author2_role | edt |
| author2_variant | w k wk |
| author_facet | Kissling, Werner |
| building | Verbundindex |
| bvnumber | BV046147006 |
| classification_rvk | YH 6105 |
| collection | ZDB-2-SME |
| ctrlnum | (ZDB-2-SME)978-3-642-86922-8 (OCoLC)1119131599 (DE-599)BVBBV046147006 |
| dewey-full | 616.89 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.89 |
| dewey-search | 616.89 |
| dewey-sort | 3616.89 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/978-3-642-86922-8 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03018nam a2200529zc 4500</leader><controlfield tag="001">BV046147006</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s1991 xx o|||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783642869228</subfield><subfield code="9">978-3-642-86922-8</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-642-86922-8</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-3-642-86922-8</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119131599</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046147006</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.89</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YH 6105</subfield><subfield code="0">(DE-625)153561:12911</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Guidelines for Neuroleptic Relapse Prevention in Schizophrenia</subfield><subfield code="b">Proceedings of a Consensus Conference held April 19–20, 1989, in Bruges, Belgium</subfield><subfield code="c">edited by Werner Kissling</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin, Heidelberg</subfield><subfield code="b">Springer Berlin Heidelberg</subfield><subfield code="c">1991</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (X, 166 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">How neuroleptics are used in relapse prevention is a very controversial topic. Fifty percent of all schizo- phrenic patients do not receive sufficient prophylactic treatment and suffer from frequent relapses. To help correct this situation, leading international experts in the field of neuroleptic relapse prevention (n.r.p.) agreed upon guidelines after intensive discussions at a consensus workshop in Bruges in April 1989. Precise guidelines to the most important questions on n.r.p. are formu- lated, especially concerning indications, treatment duration and dosage. The current state of the literature on these questions is presented in comprehensive reviews. For the practicing psychiatrist or general practitioner, exact guidelines for prophylactic treatment are presented; for patients and their families eager to obtain more information, the scientific basis of the treatment is explained</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Psychiatry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Psychiatry</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Neuroleptikum</subfield><subfield code="0">(DE-588)4041885-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Internationaler Vergleich</subfield><subfield code="0">(DE-588)4120509-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Rezidivprophylaxe</subfield><subfield code="0">(DE-588)4177967-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Schizophrenie</subfield><subfield code="0">(DE-588)4052527-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1989</subfield><subfield code="z">Brügge</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Schizophrenie</subfield><subfield code="0">(DE-588)4052527-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Neuroleptikum</subfield><subfield code="0">(DE-588)4041885-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Rezidivprophylaxe</subfield><subfield code="0">(DE-588)4177967-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Internationaler Vergleich</subfield><subfield code="0">(DE-588)4120509-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kissling, Werner</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783540539858</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783642869235</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-3-642-86922-8</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031527191</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-642-86922-8</subfield><subfield code="l">DE-355</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1989 Brügge gnd-content |
| genre_facet | Konferenzschrift 1989 Brügge |
| id | DE-604.BV046147006 |
| illustrated | Not Illustrated |
| indexdate | 2024-12-20T18:44:22Z |
| institution | BVB |
| isbn | 9783642869228 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031527191 |
| oclc_num | 1119131599 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (X, 166 p) |
| psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
| publishDate | 1991 |
| publishDateSearch | 1991 |
| publishDateSort | 1991 |
| publisher | Springer Berlin Heidelberg |
| record_format | marc |
| spelling | Guidelines for Neuroleptic Relapse Prevention in Schizophrenia Proceedings of a Consensus Conference held April 19–20, 1989, in Bruges, Belgium edited by Werner Kissling Berlin, Heidelberg Springer Berlin Heidelberg 1991 1 Online-Ressource (X, 166 p) txt rdacontent c rdamedia cr rdacarrier How neuroleptics are used in relapse prevention is a very controversial topic. Fifty percent of all schizo- phrenic patients do not receive sufficient prophylactic treatment and suffer from frequent relapses. To help correct this situation, leading international experts in the field of neuroleptic relapse prevention (n.r.p.) agreed upon guidelines after intensive discussions at a consensus workshop in Bruges in April 1989. Precise guidelines to the most important questions on n.r.p. are formu- lated, especially concerning indications, treatment duration and dosage. The current state of the literature on these questions is presented in comprehensive reviews. For the practicing psychiatrist or general practitioner, exact guidelines for prophylactic treatment are presented; for patients and their families eager to obtain more information, the scientific basis of the treatment is explained Psychiatry Neuroleptikum (DE-588)4041885-6 gnd rswk-swf Internationaler Vergleich (DE-588)4120509-1 gnd rswk-swf Rezidivprophylaxe (DE-588)4177967-8 gnd rswk-swf Schizophrenie (DE-588)4052527-2 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1989 Brügge gnd-content Schizophrenie (DE-588)4052527-2 s Neuroleptikum (DE-588)4041885-6 s Rezidivprophylaxe (DE-588)4177967-8 s Internationaler Vergleich (DE-588)4120509-1 s DE-604 Kissling, Werner edt Erscheint auch als Druck-Ausgabe 9783540539858 Erscheint auch als Druck-Ausgabe 9783642869235 https://doi.org/10.1007/978-3-642-86922-8 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Guidelines for Neuroleptic Relapse Prevention in Schizophrenia Proceedings of a Consensus Conference held April 19–20, 1989, in Bruges, Belgium Psychiatry Neuroleptikum (DE-588)4041885-6 gnd Internationaler Vergleich (DE-588)4120509-1 gnd Rezidivprophylaxe (DE-588)4177967-8 gnd Schizophrenie (DE-588)4052527-2 gnd |
| subject_GND | (DE-588)4041885-6 (DE-588)4120509-1 (DE-588)4177967-8 (DE-588)4052527-2 (DE-588)1071861417 |
| title | Guidelines for Neuroleptic Relapse Prevention in Schizophrenia Proceedings of a Consensus Conference held April 19–20, 1989, in Bruges, Belgium |
| title_auth | Guidelines for Neuroleptic Relapse Prevention in Schizophrenia Proceedings of a Consensus Conference held April 19–20, 1989, in Bruges, Belgium |
| title_exact_search | Guidelines for Neuroleptic Relapse Prevention in Schizophrenia Proceedings of a Consensus Conference held April 19–20, 1989, in Bruges, Belgium |
| title_full | Guidelines for Neuroleptic Relapse Prevention in Schizophrenia Proceedings of a Consensus Conference held April 19–20, 1989, in Bruges, Belgium edited by Werner Kissling |
| title_fullStr | Guidelines for Neuroleptic Relapse Prevention in Schizophrenia Proceedings of a Consensus Conference held April 19–20, 1989, in Bruges, Belgium edited by Werner Kissling |
| title_full_unstemmed | Guidelines for Neuroleptic Relapse Prevention in Schizophrenia Proceedings of a Consensus Conference held April 19–20, 1989, in Bruges, Belgium edited by Werner Kissling |
| title_short | Guidelines for Neuroleptic Relapse Prevention in Schizophrenia |
| title_sort | guidelines for neuroleptic relapse prevention in schizophrenia proceedings of a consensus conference held april 19 20 1989 in bruges belgium |
| title_sub | Proceedings of a Consensus Conference held April 19–20, 1989, in Bruges, Belgium |
| topic | Psychiatry Neuroleptikum (DE-588)4041885-6 gnd Internationaler Vergleich (DE-588)4120509-1 gnd Rezidivprophylaxe (DE-588)4177967-8 gnd Schizophrenie (DE-588)4052527-2 gnd |
| topic_facet | Psychiatry Neuroleptikum Internationaler Vergleich Rezidivprophylaxe Schizophrenie Konferenzschrift 1989 Brügge |
| url | https://doi.org/10.1007/978-3-642-86922-8 |
| work_keys_str_mv | AT kisslingwerner guidelinesforneurolepticrelapsepreventioninschizophreniaproceedingsofaconsensusconferenceheldapril19201989inbrugesbelgium |